Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with ...

We thank our colleagues for their interest in our Article.1 In response to Ari R Joffe, we provided estimates of the number of severe outcomes associated with a fully vaccinated counterfactual. These ...

In their Article, the HDR UK COALESCE Consortium concluded that those who are fully vaccinated against SARS-CoV-2 are less likely to be admitted to hospital and to die with COVID-19.1 If the tests for ...

Researchers from the Massachusetts Institute of Technology (MIT) and the California Institute of Technology (Caltech) have made significant strides in vaccine development that could protect against ...

Although numerous studies have shown men have more severe acute COVID cases and higher mortality than women, females in their 40s have up to a 45% higher risk of getting long COVID than men, according ...

A new experimental vaccine could offer protection not only against many variants of SARS-CoV-2, but also other sarbecoviruses that could spill over from animals to humans.

Outbreaks in commercial poultry have recently been reported in a tri-state area that makes up the Delmarva peninsula, and regional officials are collaborating on a unified response ...

MultiCare Health System announced all of its regions, including the Inland Northwest, will require masks for patients, visitors and staff in all patient care areas.

Using current estimates of US long-COVID burden (assuming the probability of long COVID is 6% and symptoms last 1 year), cases cost an average of $2.01 billion annually. The economic burden of long ...

Now, a new study from dozens of researchers across the country found that women, particularly those in middle age, have a higher risk of developing long COVID than men, muddying t ...

MIT and Caltech scientists designed a new vaccine targeting stable virus regions to protect against various coronavirus strains.

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms—including reduced physical exercise capacity and reduced cognitive test performances—for a year or more, with no ...